HHS recently released a final rule that allows practitioners in Opioid Treatment Programs to start patients on methadone or buprenorphine via telehealth. However, the final rule does not apply to the broader range of providers, leading telehealth advocates to call for additional changes from the DEA.
The American Medical Association recently released its comments on the DEA’s proposed rules for controlled substance prescribing via telemedicine. Many telehealth providers are supportive of the organization's recommendations, such as its suggestion to extend the timeframe patients have to refill their buprenorphine prescription after their initial supply is prescribed via telemedicine.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The DEA recently released proposed rules that would require an in-person visit before a patient can receive a telehealth prescription for a controlled substance. The DEA touts the change as a way to ensure patient safety, but several telehealth advocates argue it will greatly disrupt access for those who need the drugs — especially at a time when the mental health and substance use crisis is growing.
The Covid-19 public health emergency waived a rule that required a practitioner to conduct an in-person medical exam before prescribing controlled substances via telemedicine. Once the public health emergency ends on May 11, those with substance use disorder could be greatly affected, experts are warning.
At the beginning of the pandemic, we were celebrated as heroes. Now the heroes are asking for help in addressing this new phenomenon of empathy fatigue. If we fail to ignore this crisis of compassion, patients and clinicians will continue to suffer.
Leaders in healthcare draw attention to the myriad ways cloud computing technology is transforming healthcare.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Four experts with the VA, Providence St. Joseph Health, Microsoft and One Medical shared what is needed for continued adoption of telehealth. Most pointed to better integration with clinical workflows and new payment models as future drivers for growth.
During a Monday hearing, the Senate Committee on Health, Education, Labor and Pensions discussed which changes to telehealth coverage made during the Covid-19 pandemic should stay.
With Sansoro's solution, a telehealth platform can access EHR data and get it in real time, CMO Dave Levin explained in an interview at this year's American Telemedicine Association conference.
There are numerous ways AI is being used at the patient bedside, and even big companies like Google are leveraging the technology in healthcare. But it'll be some time before machines completely take over for clinicians.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
At the American Telemedicine Association conference, Gist Healthcare cofounder and president Dr. Lisa Bielamowicz discussed how industry disruptors like Walmart are reframing how the healthcare industry looks at consumer value.
Ann Mond Johnson, who previously served as CEO of Zest Health, a Chicago-based digital technology company, has been named CEO of the American Telemedicine Association. She will officially take the reins March 5.
After 24 years in his position, ATA CEO Jonathan Linkous is departing. ATA COO Sabrina Smith will serve as interim CEO until a permanent replacement is found.
At the American Telemedicine Association conference, MedCity chatted with Dr. Henry DePhillips, Teladoc's chief medical officer.
During a plenary session at the ATA conference, a group of strategic investors shared their ideas on the growing field of telehealth.